We obtained the iPSC-derived neural cells at different differentiation stages: neural progenitors (NPs) and terminally differentiated neurons (DNs) from both healthy donors and PD patients with the PARK2 gene mutations. This evidence concerns the gene PRKN and Parkinson disease.